Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-11-09 Sale |
2022-11-14 6:43 pm |
Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO |
162,500 | $1.5 | $243,750 | 1,975,358 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-04-29 Option Award |
2022-05-02 12:23 pm |
N/A N/A |
Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO |
10,532 | $1 | 2,137,858 (Direct) |
View |
| 2022-03-04 Option Award |
2022-04-26 9:29 pm |
2022-03-04 2032-03-04 |
Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO |
191,672 | $0 | 191,672 (Direct) |
View |
| 2021-12-06 Ownership |
2022-04-26 9:25 pm |
2021-12-01 2022-01-31 |
Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO |
160,000 | $0 | 4,562,596 (Direct) |
View |
| 2021-12-30 Ownership |
2022-04-26 9:25 pm |
2021-12-01 2022-01-31 |
Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO |
1,137,635 | $0 | 4,562,596 (Direct) |
View |
| 2021-12-30 Ownership |
2022-04-26 9:25 pm |
N/A N/A |
Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO |
1,137,635 | $0.2 | 4,562,596 (Direct) |
View |
| 2021-12-01 Ownership |
2022-04-26 9:25 pm |
2021-12-01 2022-01-31 |
Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO |
1,297,635 | $0 | 4,562,596 (Direct) |
View |
| 2020-10-05 Ownership |
2022-04-26 9:22 pm |
N/A N/A |
Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO |
432,545 | $0.4 | 2,287,326 (Direct) |
View |
| 2020-10-05 Ownership |
2022-04-26 9:22 pm |
2020-10-05 2025-10-05 |
Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO |
1,297,635 | $0 | 2,287,326 (Direct) |
View |